NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026

NeurAxis (NYSE American: NRXS) will report summarized fourth quarter and full year 2025 results for the period ended December 31, 2025, on Thursday, March 19, 2026, before market open.

Rhea-AI Summary

NeurAxis (NYSE American: NRXS) will report summarized fourth quarter and full year 2025 results for the period ended December 31, 2025, on Thursday, March 19, 2026, before market open.

The company will host a conference call and live webcast on March 19, 2026 at 9:00am ET; webcast and replay will be available in the Investor Relations section of the company's website. Participants can submit questions via the webcast portal or by emailing NRXS@lythampartners.com.

Argus Mar 12 session

+0.47% close to close Open Argus

Details

News Market Reaction – NRXS

In the Mar 12 session, NRXS gained 0.47%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules NeurAxis’ Q4 and full-year 2025 results for March 19, 2026, continuing a...

Analysis

This announcement schedules NeurAxis’ Q4 and full-year 2025 results for March 19, 2026, continuing a steady cadence of detailed financial updates. Prior quarters showed strong revenue growth and expanding insurance coverage, but share reactions were mixed. Investors may focus on whether momentum from earlier periods persists, how operating losses and cash evolve, and how new reimbursement and coverage wins translate into sustainable revenue and margin trends.

Key Figures

Results date: March 19, 2026 Quarter end date: December 31, 2025 Conference call time: 9:00 am ET

Results date

March 19, 2026

Q4 and full-year 2025 results release before market open

Quarter end date

December 31, 2025

Period end for Q4 and FY2025 results

Conference call time

9:00 am ET

Scheduled earnings and business update call on March 19, 2026

Previous Earnings Reports

5 past events · Latest: Nov 11

Same Type 5 events

1. Nov 11

   Q3 2025 earnings

   24h Move

   -5.9%

   Reported 22% YoY revenue growth and multiple FDA clearances for IB-Stim.

2. Aug 12

   Q2 2025 earnings

   24h Move

   +2.5%

   Revenues grew 46% YoY with lower operating expenses and improved loss.

3. May 12

   Q1 2025 earnings

   24h Move

   +16.0%

   Revenues increased 39% YoY and covered lives expanded sharply.

4. Mar 20

   Q4 2024 earnings

   24h Move

   -0.9%

   Q4 revenue up 43% and FY2024 revenue up 9% versus 2023.

5. Jan 08

   Prelim Q4 2024

   24h Move

   -3.9%

   Preliminary Q4 showed ~50% revenue growth and full-year revenue up 11%.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CARMEL, Ind., March 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized financial results for its fourth quarter and fiscal year 2025, for the period ended December 31, 2025, on Thursday, March 19, 2026, before market open. The Company has scheduled a conference call for the same day, Thursday, March 19, 2026, at 9:00 am ET to review the results.

Conference Call Details

Date and Time: Thursday, March 19, 2026, at 9:00am ET

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company's website at https://ir.neuraxis.com/ or https://edge.media-server.com/mmc/p/4ig827me. For participants listening through the webcast, questions can be sent in through the portal using the “Ask a Question” link or by emailing questions to NRXS@lythampartners.com.

Call-in Information: Interested parties can also access the live conference call by initially registering at the following link. Upon completion of the registration link, call-in participants will receive the dial-in info and a unique PIN to join the call as well as an email confirmation with the details.

Replay: A webcast replay will be available in the Investor Relations section of the Company's website at https://ir.neuraxis.com/ or https://edge.media-server.com/mmc/p/4ig827me.

About NeurAxis, Inc.
NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive adoption of IB-Stim® , which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is FDA cleared for functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD), and FD-related nausea symptoms in patients 8 years and older. Additional clinical trials of PENFS in multiple pediatric and adult conditions with large unmet healthcare needs are underway.

For more information, please visit http://neuraxis.com.

Investor Relations
Lytham Partners
Ben Shamsian
646-829-9701
shamsian@lythampartners.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will NeurAxis (NRXS) report Q4 and full year 2025 results?

NeurAxis will report results on Thursday, March 19, 2026, before market open. According to the company, the results cover the period ended December 31, 2025 and will be followed by a conference call at 9:00am ET.

How can investors join the NeurAxis (NRXS) March 19, 2026 earnings call?

Investors can join via a live webcast or by phone registration for dial-in details and a PIN. According to the company, phone participants must register to receive call-in information and a unique PIN ahead of the call.

Where will the NeurAxis (NRXS) webcast and replay be posted?

The live webcast and replay will be posted in the Investor Relations section of the company's website. According to the company, the webcast links are available at ir.neuraxis.com and the media-server replay URL provided by the company.

What time is the NeurAxis (NRXS) conference call on March 19, 2026?

The conference call is scheduled for 9:00am ET on March 19, 2026. According to the company, the call occurs after the release of summarized financial results released before market open the same day.

How can participants submit questions during the NeurAxis (NRXS) webcast?

Participants can submit questions through the webcast portal's “Ask a Question” link or via email. According to the company, questions may be emailed to NRXS@lythampartners.com prior to or during the live webcast.

Will there be a replay of the NeurAxis (NRXS) March 19, 2026 call and how long will it be available?

A webcast replay will be available on the company's Investor Relations website after the call. According to the company, the replay link will be posted at ir.neuraxis.com and on the provided media-server replay page.